Last checked at 18 Jun 2012 07:00
Port Erin Biopharma Investments Limited
("Port Erin" or the "Company")
Director's Dealing
Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, was informed that Galloway Limited purchased 500,000 Ordinary Shares at a price of 7 pence per share on 15 June 2012.
Galloway Limited is wholly owned by a trust in which Jim Mellon, Chairman of the Company, has a life tenancy. Denham Eke, a Director of the Company, is a director of Galloway Limited.
Following this transaction, the total Ordinary Shares in which Jim Mellon has a beneficial interest is 3,941,000, representing 11.8% of the issued ordinary share capital of the Company.
Enquiries:
| |||
Port Erin Biopharma Investments Limited |
| ||
Denham Eke | (+44) 1624 639396 | ||
|
| ||
Libertas Capital Corporate Finance Limited |
| ||
Sandy Jamieson | (+44) 20 7569 9650 | ||
|
| ||
Rivington Street Corporate Finance Limited |
| ||
John Levinson | (+44) 20 7562 3350 | ||